Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Learning Design and Innovation, Dartmouth College, Hanover, NH, USA.
Harm Reduct J. 2024 Aug 24;21(1):154. doi: 10.1186/s12954-024-01062-2.
Illicitly manufactured fentanyl and its analogs are the primary drivers of opioid overdose deaths in the United States (U.S.). People who use drugs may be exposed to fentanyl or its analogs intentionally or unintentionally. This study sought to identify strategies used by rural people who use drugs to reduce harms associated with unintentional fentanyl exposure.
This analysis focused on 349 semi-structured qualitative interviews across 10 states and 58 rural counties in the U.S conducted between 2018 and 2020. Interview guides were collaboratively standardized across sites and included questions about drug use history (including drugs currently used, frequency of use, mode of administration) and questions specific to fentanyl. Deductive coding was used to code all data, then inductive coding of overdose and fentanyl codes was conducted by an interdisciplinary writing team.
Participants described being concerned that fentanyl had saturated the drug market, in both stimulant and opioid supplies. Participants utilized strategies including: (1) avoiding drugs that were perceived to contain fentanyl, (2) buying drugs from trusted sources, (3) using fentanyl test strips, 4) using small doses and non-injection routes, (5) using with other people, (6) tasting, smelling, and looking at drugs before use, and (7) carrying and using naloxone. Most people who used drugs used a combination of these strategies as there was an overwhelming fear of fatal overdose.
People who use drugs living in rural areas of the U.S. are aware that fentanyl is in their drug supply and use several strategies to prevent associated harms, including fatal overdose. Increasing access to harm reduction tools (e.g., fentanyl test strips, naloxone) and services (e.g., community drug checking, syringe services programs, overdose prevention centers) should be prioritized to address the polysubstance-involved overdose crisis. These efforts should target persons who use opioids and other drugs that may contain fentanyl.
在美国,非法制造的芬太尼及其类似物是阿片类药物过量死亡的主要驱动因素。吸毒者可能会有意或无意地接触到芬太尼或其类似物。本研究旨在确定农村吸毒者用来减少意外接触芬太尼相关危害的策略。
本分析重点关注了 2018 年至 2020 年期间在美国 10 个州和 58 个农村县进行的 349 次半结构式定性访谈。访谈指南在各地点进行了合作标准化,包括吸毒史(包括目前使用的药物、使用频率、给药方式)和特定于芬太尼的问题。采用演绎编码对所有数据进行编码,然后由跨学科写作团队对过量用药和芬太尼编码进行归纳编码。
参与者表示担心芬太尼已经充斥了毒品市场,包括兴奋剂和阿片类药物供应。参与者采用了以下策略:(1)避免被认为含有芬太尼的药物,(2)从可信来源购买药物,(3)使用芬太尼检测条,(4)使用小剂量和非注射途径,(5)与他人一起使用,(6)在使用前品尝、嗅闻和观察药物,以及(7)携带和使用纳洛酮。大多数吸毒者使用这些策略的组合,因为他们对致命过量的恐惧是压倒性的。
居住在美国农村地区的吸毒者意识到芬太尼存在于他们的毒品供应中,并使用了几种策略来防止相关危害,包括致命过量。应优先考虑增加减少伤害工具(例如芬太尼检测条、纳洛酮)和服务(例如社区药物检测、注射器服务计划、过量预防中心)的获取,以应对多物质滥用相关的过量危机。这些努力应针对使用阿片类药物和其他可能含有芬太尼的药物的人。